Bulging fontanelle after supplementation with 25,000 IU of vitamin A in infancy using immunization contacts

Area of Science:

• Pediatrics
• Nutritional Science
• Public Health

Background:

• Vitamin A is crucial for infant development and immune function.
• Early infancy is a critical period for growth and susceptibility to infections.
• Immunization programs provide opportunities for targeted nutritional interventions.

Purpose of the Study:

• To assess the safety of vitamin A supplementation in infants during routine immunization.
• To investigate potential adverse events associated with high-dose vitamin A in early life.
• To evaluate the relationship between vitamin A dosage and specific side effects.

Main Methods:

• A double-blind, randomized, placebo-controlled trial was conducted in Bangladesh.
• 167 infants received three doses of 25,000 IU vitamin A or placebo alongside DPT/OPV immunizations.
• Infants were monitored by physicians for adverse events, including fontanelle bulging, post-supplementation.

Main Results:

• Nine infants (10.5%) receiving vitamin A experienced bulging fontanelle, compared to two (2.5%) in the placebo group (p < 0.05).
• Most episodes (12/14) occurred in the vitamin A group, with increasing frequency after the second and third doses.
• A cumulative effect was suggested, as more doses correlated with a higher likelihood of bulging fontanelle.

Conclusions:

• Vitamin A supplementation in early infancy, especially with multiple doses, may be associated with an increased incidence of bulging fontanelle.
• The findings suggest a potential causal link and cumulative effect of vitamin A on this specific adverse event.
• Further research is warranted to clarify the safety profile and optimal dosing of vitamin A in infants during immunization programs.